Spatial Proteomics in Cancer Risk Predictions

AI-enabled spatial proteomics enhances risk assessment for Barrett's esophagus.

15 percent of low-risk patients were reclassified at higher risk.

Test uses existing biopsy samples, adding to efficiency.

Improves patient outcomes with risk-aligned care.

Supports informed decision-making for surveillance and treatment.

Potential impact on lowering esophageal cancer incidence.

Integration into current practices is seamless.